EPISODE · May 21, 2026 · 5 MIN
S7 E1: How Theramex walked away from PMCPA jurisdiction and what it means for pharma self-regulation
from Code Clarity · host Code Clarity
Theramex is the third UK pharma company to leave PMCPA jurisdiction in three years (Sandoz 2023, Evolus 2024, Theramex 2026). Does that reflect increasing rules, companies avoiding audit, or self-regulation management of issues? Rina & Jean discuss how we got here and what it means for the future of self-regulation.
What this episode covers
Theramex is the third UK pharma company to leave PMCPA jurisdiction in three years (Sandoz 2023, Evolus 2024, Theramex 2026). Does that reflect increasing rules, companies avoiding audit, or self-regulation management of issues? Rina & Jean discuss how we got here and what it means for the future of self-regulation.
NOW PLAYING
S7 E1: How Theramex walked away from PMCPA jurisdiction and what it means for pharma self-regulation
No transcript for this episode yet
Similar Episodes
May 7, 2026 ·8m
Apr 29, 2026 ·48m
Apr 29, 2026 ·106m